Pathogenicity of LRRK2 P755L variant in Parkinson's disease

Authors

  • Eng-King Tan MD, FRCP,

    Corresponding author
    1. Department of Neurology, Singapore General Hospital, National Neuroscience Institute, Singapore
    2. Department of Neurology, National Neuroscience Institute, Singapore
    3. Department of Neurology, SingHealth Research, Singapore
    • Department of Neurology, Singapore General Hospital, National Neuroscience Institute, Outram Road, Singapore 169608

    Search for more papers by this author
  • Hui-Qin Lim BSc,

    1. Department of Neurology, Singapore General Hospital, National Neuroscience Institute, Singapore
    Search for more papers by this author
  • Yih Yuen MD,

    1. Department of Health Screening, Singapore General Hospital, Singapore
    Search for more papers by this author
  • Yi Zhao MD, PhD

    1. Department of Clinical Research, Singapore General Hospital, Singapore
    Search for more papers by this author

Abstract

A heterozygous 2264C→T variant (P755L) in LRRK2 gene has been reported to be a likely pathogenic variant among ethnic Chinese patients with Parkinson's disease (PD). In a case control study, we performed genetic analysis of the P755L variant in an independent cohort of Chinese patients with PD and controls. The P755L variant was present in 4/204 (2.0%) of PD compared with 6/235 (2.6%) of controls (odds ratio = 0.76, 95% CI 0.23, 2.6, P = 0.76). All subjects carried the heterozygous genotype. Subset analysis in the group ≥65 years of age revealed a prevalence of 2.8% in PD compared with 3.1% in controls (odds ratio = 0.92, 95% CI 022, 3.7, P = 0.9), and in the group <65 years of age showed a 0% in PD versus 2.1% in controls (P = 0.2). The phenotype of patients with PD with the P755L variant was generally similar to other patients with PD and none of the carriers reported a positive family history. The lack of functional data, absence of segregation of the variant with disease, and the presence of the variant in apparently healthy individuals suggest that P755L is possibly a rare polymorphism in the Chinese population. Further validation of our findings in other populations would be important. © 2008 Movement Disorder Society

Ancillary